Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAccess to the study record now results in a 403 Forbidden error, replacing the study details with a standard error page. The page displays a 403 header and site footer.SummaryDifference18%

- Check19 days agoChange DetectedPlatform revision updated from v3.6.6 to v3.7.0, indicating a portal/UI update rather than changes to the study details.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a new published version of the page. This appears to be a backend/version metadata update rather than a visible content change.SummaryDifference0.0%

- Check40 days agoChange DetectedThis change adds a new entry 2019 ( U.S. NIH Grant/Contract ) under the study's Other Study ID Numbers, indicating NIH funding for the U.S. portion of the trial. It clarifies the funding source associated with the study's U.S. contribution.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a new page revision and updating the page's metadata.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a backend/UI update to the page without altering the study data.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.